Aptar Pharma Sets Up Production Near Mumbai

From the wire: Aptar Pharma, which develops and manufactures nasal and pulmonary drug-delivery devices, has announced the opening of a new facility near Mumbai, India.

Located at Rabale, Navi Mumbai, the new site includes an ISO Class 7 cleanroom, which will be used primarily to produce the DF30 metering valve platform for metered dose inhalers and to assemble spray pumps.

Established in 1999 in Mumbai, Aptar Pharma provides aerosol, spray and dispensing systems to biotechnology, healthcare and pharmaceutical companies in India.

The site was officially inaugurated on 21 January 2012 in the presence of Ajit Singh, chairman of ACG Worldwide; Dr C. Gopalakrishna Murty, President of the Indian Pharmaceutical Association; and business partners and suppliers as well as AptarGroup senior management representatives including CEO Stephen J. Hagge.

Tags: Aptar pharma, drug delivery, india